Krishnansu Tewari
Director Division of Gynecologic Oncology · University of California
Credentials: · · · · · ·
History
- Present
- 2003–2006
University of California
- 1999–2003
University of California
Research
Improved survival with bevacizumab in advanced cervical cancer
New England Journal of Medicine · 2014 · First of 12 authors · 1,127 citations
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
New England Journal of Medicine · 2021 · 855 citations
The Lancet · 2017 · First of 23 authors · Corresponding · 530 citations
85 papers · 2 as a resident
- PD
26 papers
22 papers · 4 as a fellow
- RB
22 papers · 2 as a fellow
22 papers
20 papers · 1 as a resident
18 papers
- RC
17 papers
Grants
- 1997–2022
National Cancer Institute · P30
Project lead · $374.6K · University of California-Irvine
- 2011–2015
Novel Biologic Markers of Treatment Resistance in Locally Advanced Cervical Carci
National Cancer Institute · R21
Contact PI · $358.7K · University of California-Irvine
Clinical trials
- 2014–2017
Principal investigator · Completed · Phase 1
University of California, Irvine
- 2009–2013
Principal investigator · Completed · Phase 3
National Cancer Institute (NCI)
- 2007–2008
Safety and Efficacy Study of Glufosfamide in Ovarian Cancer
Principal investigator · Terminated · Phase 2
Eleison Pharmaceuticals LLC.
- 2022–2027
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)